Le Lézard
Classified in: Health, Business
Subject: TNM

Revelstoke Completes Exit of Carrus


DENVER, Oct. 13, 2021 /PRNewswire/ -- Revelstoke Capital Partners ("Revelstoke"), a Denver-based private equity firm, announced today that it has successfully exited its investment in Carrus (the "Company") through the Company's combination with Penn Foster.

Carrus delivers quality, trusted healthcare learning content, continuing education, and certification management to new learners, healthcare professionals, and institutions through an integrated technology platform that provides a seamless healthcare learning experience. In 25+ years, Carrus, through its CareerStep and CareerCert divisions, has trained over 150,000 learners for new careers, partnered with more than 150 colleges and universities nationwide, and educated more than 100,000 healthcare professionals."

Misty Frost, CEO of Carrus, said, "The strategic healthcare expertise that Revelstoke brought to Carrus and its strong support of our growth initiatives was invaluable as we expanded our reach to become one of the nation's most trusted digital healthcare training and professional development providers. We are excited about the opportunity to join the Penn Foster family and continue building on a shared vision of empowering our learners through powerful education and training tools."

"Revelstoke's mission to help build leading healthcare service and technology companies would not be possible without exceptional management teams," said Russell Cassella, Managing Partner of Revelstoke. "Misty and the Carrus team have spurred tremendous growth for the Company through their strategic vision and in the face of ever-growing demand for training in the healthcare services sector. We are extremely proud of what Carrus has achieved and look forward to seeing the business continue to thrive through its new partnership with Penn Foster."

William Blair & Company, LLC and Winston & Strawn LLP acted as financial advisor and legal counsel, respectively, to Carrus.

About Carrus

Carrus delivers quality, trusted healthcare learning content, continuing education, and certification management to new learners, healthcare professionals, and institutions through an integrated technology platform that provides a seamless healthcare learning experience. In 25+ years, Carrus, through its CareerStep and CareerCert divisions, has trained over 150,000 learners for new careers, partnered with more than 150 colleges and universities nationwide, and educated more than 100,000 healthcare professionals."

About Revelstoke Capital Partners

Revelstoke is a private equity firm formed by experienced investors who focus on building industry-leading companies in the healthcare and related health and wellness sectors. Revelstoke partners with entrepreneurs and management teams to execute on a disciplined organic and acquisition growth strategy as it strives to build exceptional companies. Revelstoke is based in Denver, Colorado and has approximately $3.8 billion of assets under management, which includes uncalled capital commitments made to Revelstoke-managed vehicles. Since the Firm's inception in 2013, Revelstoke has completed 112 acquisitions, which include 21 platform companies and 91 add-on acquisitions.

Contact:
Caroline Luz
Lambert & Co.
203-656-2829
[email protected]

SOURCE Revelstoke Capital Partners


These press releases may also interest you

at 12:06
Maid Sailors Cleaning Service has joined forces with Cleaning for a Reason, a non-profit organization offering free house cleaning services to cancer patients across the United States and Canada....

at 12:05
Terragia Biofuel, a technology startup aiming to drive the next generation of biofuels, today announced it has raised a $6 million seed round led by Engine Ventures and Energy Impact Partners (EIP). The company will use the capital to commercialize...

at 12:05
Float, the marketplace moving all the care that doesn't need a hospital to the home, today announced $10 million in Series A funding led by Canvas Ventures, whose General Partner Mike Ghaffary has joined Float's board, with participation from Wave...

at 12:00
V-Wave today announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American College of Cardiology's (ACC) Annual Scientific Session & Expo taking place April 6-8 in Atlanta. RELIEVE-HF is a randomized, double-blind,...

at 12:00
Critical Path Institute's (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of a groundbreaking model-based Clinical Trial Simulator (CTS), specifically designed to improve design of efficacy studies for...

at 11:45
SummaryProduct: Henna cones Issue: Chemical hazard / Product safety What to do: Stop using and selling them immediately and dispose of them in regular household garbage Who this is for: General public / Industry; Retail, Importers IssueHealth Canada...



News published on and distributed by: